Treatment, privacy concerns arise with availability of Alzheimer's test

11/15/2012 | New York Times (tiered subscription model), The

As more practices start to use imaging scans for diagnosing Alzheimer's disease, experts worry that the availability of the scans is getting ahead of availability of treatments for those who test positive. Treatment options are limited or not available for some forms of dementia. In one case, the family of an Arizona woman diagnosed with Alzheimer's through a scan refused to enroll her in an experimental study for fear of potential adverse side effects and instead turned to the Internet for treatments.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director Quality Improvement
Molina Healthcare of Texas
San Antonio, TX
Senior Medical Director
Network Health
Medford, MA
SVP/Head of Health Plans and Managed Care
Avalere Health
Washington, DC
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR